DEBx Medical
DEBx Medical is a medical technology company dedicated to revolutionizing chronic wound management by providing innovative, easy-to-use treatments that improve patient outcomes worldwide. Their flagship product, DEBRICHEM®, is a topical dehydrating agent that removes infection and biofilm in hard-to-heal wounds within 60 seconds, supporting faster healing and reducing the need for surgical debridement and antibiotics. The company focuses on delivering disruptive wound care solutions, investing in research and development, and expanding its product portfolio to cover all phases of wound care. Headquartered in the Netherlands, DEBx Medical operates globally with a network of dedicated partners and aims to file for FDA approval in 2024.
Industries
Nr. of Employees
small (1-50)
DEBx Medical
Rotterdam, Zuid-Holland, The Netherlands, Europe
Patents
Compositions for removing necrotic or infected tissues from body surface lesions and from oral cavity
US-12208072-B2
View Details
Compositions for removing necrotic or infected tissues from body surface lesions and from oral cavity
US-12208072-B2
View DetailsProducts
Topical acidic desiccant formulation for non-surgical debridement
Topical desiccant intended for non-surgical removal of biofilm and associated microbes in hard-to-heal wounds by rapid desiccation of exposed wound material; described for professional clinical use with a short application dwell time.
Topical acidic desiccant formulation for non-surgical debridement
Topical desiccant intended for non-surgical removal of biofilm and associated microbes in hard-to-heal wounds by rapid desiccation of exposed wound material; described for professional clinical use with a short application dwell time.
Services
Free in-facility demonstrations where clinicians can observe and treat patients using the topical chemical debridement procedure and evaluate clinical workflow integration.
Commercial partnership offering materials, market information and onboarding support for regional distributors to expand product availability.
Recorded presentations, webinars and case-study videos for clinicians covering mechanism of action, clinical cases, procedural guidance and safety on intact skin.
Free in-facility demonstrations where clinicians can observe and treat patients using the topical chemical debridement procedure and evaluate clinical workflow integration.
Commercial partnership offering materials, market information and onboarding support for regional distributors to expand product availability.
Recorded presentations, webinars and case-study videos for clinicians covering mechanism of action, clinical cases, procedural guidance and safety on intact skin.
Expertise Areas
- Topical chemical debridement for chronic wounds
- Biofilm eradication strategies in wound care
- Clinical pathway development for wound management
- Preclinical ex vivo infection modeling and clinical case-series evaluation
Key Technologies
- Topical desiccant formulations
- Biofilm desiccation chemistry (water-binding mechanisms)
- Integration with negative pressure wound therapy (NPWT)
- Ex vivo human explant infection models
News & Updates
EWMA 2025 Conference in Barcelona
A showcase of innovation, collaboration, and engagement in wound care at EWMA 2025 in Barcelona.
Upcoming XVIII AIUC National Congress 2025 in Italy
An upcoming event in Bari, Italy, for wound care professionals.
15th Abu Dhabi Wound Care Conference
A scientific event and company dinner in Abu Dhabi, highlighting advances in wound care.
EWMA 2025 Conference in Barcelona
A showcase of innovation, collaboration, and engagement in wound care at EWMA 2025 in Barcelona.
Upcoming XVIII AIUC National Congress 2025 in Italy
An upcoming event in Bari, Italy, for wound care professionals.
15th Abu Dhabi Wound Care Conference
A scientific event and company dinner in Abu Dhabi, highlighting advances in wound care.